Speedy weight loss from drugs used to fight obesity and diabetes has left some users looking gaunt and aged. The boss of Swiss skincare group Galderma thinks treatments for what has been dubbed “Ozempic face” could give the company a lift.
Related Posts
Toyota Shareholder Support for Chairman Akio Toyoda Falls Sharply
Toyoda was re-elected to the board with just under 72% support, down from more than 95% in 2022, suggesting rising dissatisfaction with corporate governance at […]
Container-Ship Stocks Fall After U.S. Port Strike Ends
Shares dropped as much as 16% as the agreement nixed for now the prospects of higher freight rates.
Pfizer’s Strong Quarter Bolsters CEO’s Comeback Efforts
The pharmaceutical company reported its third consecutive quarter with positive results.